Yale University

Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice.

TitlePharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice.
Publication TypeJournal Article
Year of Publication2006
AuthorsBruce, Douglas R., Frederick L. Altice, Marc N. Gourevitch, and Gerald H. Friedland
JournalJournal of acquired immune deficiency syndromes (1999)
Volume41
Issue5
Pagination563-72
Date Published2006 Apr 15
ISSN1525-4135
KeywordsAcquired Immunodeficiency Syndrome, Analgesics, Opioid, Anti-HIV Agents, Buprenorphine, Drug Interactions, HIV Infections, Humans, Methadone
AbstractOpioid dependence and HIV/AIDS are 2 of the most serious yet treatable diseases worldwide. Global access to opioid agonist therapy and HIV treatment is expanding but when concurrently used, problematic pharmacokinetic drug interactions can occur.
DOI10.1007/s11904-011-0095-3
Alternate JournalJ. Acquir. Immune Defic. Syndr.

External Links